{"id":180837,"date":"2024-12-04T16:26:14","date_gmt":"2024-12-04T15:26:14","guid":{"rendered":"https:\/\/clinical.r-biopharm.com\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/"},"modified":"2024-12-20T12:23:39","modified_gmt":"2024-12-20T11:23:39","slug":"r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb","status":"publish","type":"post","link":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/","title":{"rendered":"Nuovo strumento per la lotta contro la Tubercolosi (TB)"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">R-Biopharm lancia una nuova generazione di test per la diagnosi della tubercolosi basata sull&#8217; IP-10.<\/h2>\n\n\n\n<p>Questo rappresenta un avanzamento significativo rispetto ai tradizionali test di rilascio dell\u2019interferone-gamma. Questo innovativo metodo diagnostico si basa sulla rilevazione del biomarcatore IP-10 (proteina indotta da interferone-gamma 10), che viene secreto in concentrazioni fino a 100 volte superiori rispetto all&#8217;INF-gamma, a seguito di una stimolazione mirata delle cellule T con antigeni della tubercolosi. Il sistema comprende tre provette e due soluzioni differenti: un&#8217;opzione ideale per laboratori di medio-alta capacit\u00e0 (ELISA) e una soluzione per laboratori di dimensioni pi\u00f9 piccole o in localit\u00e0 remote con attrezzature limitate, grazie al test a flusso laterale. Tutti i kit sono approvati CE IVDR, garantendo elevati standard di qualit\u00e0 e sicurezza.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-top\" style=\"grid-template-columns:30% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"262\" src=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_tubes-300x262.png\" alt=\"\" class=\"wp-image-180777 size-medium\" srcset=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_tubes-300x262.png 300w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_tubes.png 651w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><strong>RIDA\u00aeTB Tubes<\/strong><\/p>\n\n\n\n<p>\u2022 Utilizzo di campioni di sangue intero<\/p>\n\n\n\n<p>\u2022 Induzione di IP-10 in 16 ore<\/p>\n\n\n\n<p> \u2022 Solo 3 provette per paziente <\/p>\n\n\n\n<p>\u2022 Compatibile con: RIDASCREEN\u00ae TB (ELISA) e RIDA\u00aeQUICK TB (Test rapido)<\/p>\n\n\n\n<p><\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-top\" style=\"grid-template-columns:30% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-1024x1024.png\" alt=\"\" class=\"wp-image-180790 size-medium\" srcset=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-1024x1024.png 1024w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-300x300.png 300w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-150x150.png 150w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-1536x1536.png 1536w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-2048x2048.png 2048w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_ridascreen-60x60.png 60w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><strong>RIDASCREEN\u00ae TB<\/strong><\/p>\n\n\n\n<p>\u2022 Uso di plasma indotto con le provette RIDA\u00aeTB <\/p>\n\n\n\n<p>\u2022 56 determinazioni per kit <\/p>\n\n\n\n<p>\u2022 Risultati in 120 minuti <\/p>\n\n\n\n<p>\u2022 Adatto per analisi automatica o manuale<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-top\" style=\"grid-template-columns:30% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-1024x1024.png\" alt=\"\" class=\"wp-image-180784 size-medium\" srcset=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-1024x1024.png 1024w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-300x300.png 300w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-150x150.png 150w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-1536x1536.png 1536w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-2048x2048.png 2048w, https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/tb_flyer-a5_en_rida_quick-60x60.png 60w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><strong>RIDA\u00aeQUICK TB<\/strong><\/p>\n\n\n\n<p>\u2022 Uso di plasma indotto con le provette RIDA\u00aeTB <\/p>\n\n\n\n<p>\u2022 25 determinazioni per kit <\/p>\n\n\n\n<p>\u2022 Risultati in 15 minuti <\/p>\n\n\n\n<p>\u2022 Lettura ed interpretazione dei risultati con RIDA\u00aeQ3<\/p>\n\n\n\n<p><\/p>\n<\/div><\/div>\n\n\n\n<p><strong>Vuoi ricevere maggiori informazioni? <\/strong><\/p>\n\n\n\n<p><strong>Compila il modulo sottostante per metterti in contatto direttamente con il team R-Biopharm.<\/strong><\/p>\n\n\n\n\n\t\t\t\t\t\t<script>\n\t\t\t\t\t\t\twindow.hsFormsOnReady = window.hsFormsOnReady || [];\n\t\t\t\t\t\t\twindow.hsFormsOnReady.push(()=>{\n\t\t\t\t\t\t\t\thbspt.forms.create({\n\t\t\t\t\t\t\t\t\tportalId: 4832203,\n\t\t\t\t\t\t\t\t\tformId: \"9dd5ee96-d585-45e9-ba23-f99fb199949b\",\n\t\t\t\t\t\t\t\t\ttarget: \"#hbspt-form-1775465387000-4875497963\",\n\t\t\t\t\t\t\t\t\tregion: \"na1\",\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t})});\n\t\t\t\t\t\t<\/script>\n\t\t\t\t\t\t<div class=\"hbspt-form\" id=\"hbspt-form-1775465387000-4875497963\"><\/div>\n\n\n","protected":false},"excerpt":{"rendered":"<p>R-Biopharm lancia una nuova generazione di test per la diagnosi della tubercolosi basata sull&#8217; IP-10. Questo rappresenta un avanzamento significativo rispetto ai tradizionali test di rilascio dell\u2019interferone-gamma. Questo innovativo metodo diagnostico si basa sulla rilevazione del biomarcatore IP-10 (proteina indotta da interferone-gamma 10), che viene secreto in concentrazioni fino a 100 volte superiori rispetto all&#8217;INF-gamma, [&hellip;]<\/p>\n","protected":false},"author":330,"featured_media":180800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"95884,173111,95878,95885,95862,95851","_relevanssi_noindex_reason":"","footnotes":""},"categories":[758],"tags":[],"class_list":["post-180837","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostica-della-tubercolosi"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics\" \/>\n<meta property=\"og:description\" content=\"R-Biopharm lancia una nuova generazione di test per la diagnosi della tubercolosi basata sull&#8217; IP-10. Questo rappresenta un avanzamento significativo rispetto ai tradizionali test di rilascio dell\u2019interferone-gamma. Questo innovativo metodo diagnostico si basa sulla rilevazione del biomarcatore IP-10 (proteina indotta da interferone-gamma 10), che viene secreto in concentrazioni fino a 100 volte superiori rispetto all&#8217;INF-gamma, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Diagnostics\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T15:26:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-20T11:23:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"930\" \/>\n\t<meta property=\"og:image:height\" content=\"339\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"simonpatasic\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"simonpatasic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\"},\"author\":{\"name\":\"simonpatasic\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d\"},\"headline\":\"Nuovo strumento per la lotta contro la Tubercolosi (TB)\",\"datePublished\":\"2024-12-04T15:26:14+00:00\",\"dateModified\":\"2024-12-20T11:23:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\"},\"wordCount\":240,\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg\",\"articleSection\":[\"Diagnostica della tubercolosi\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\",\"url\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\",\"name\":\"Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg\",\"datePublished\":\"2024-12-04T15:26:14+00:00\",\"dateModified\":\"2024-12-20T11:23:39+00:00\",\"author\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d\"},\"breadcrumb\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage\",\"url\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg\",\"contentUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg\",\"width\":930,\"height\":339},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/clinical.r-biopharm.com\/it\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuovo strumento per la lotta contro la Tubercolosi (TB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\",\"url\":\"https:\/\/clinical.r-biopharm.com\/fr\/\",\"name\":\"Clinical Diagnostics\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d\",\"name\":\"simonpatasic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ece836a5d732f88c095eac6e0cccdde834cf8509c9c57d650e20ad1a0c0637bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ece836a5d732f88c095eac6e0cccdde834cf8509c9c57d650e20ad1a0c0637bd?s=96&d=mm&r=g\",\"caption\":\"simonpatasic\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/","og_locale":"it_IT","og_type":"article","og_title":"Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics","og_description":"R-Biopharm lancia una nuova generazione di test per la diagnosi della tubercolosi basata sull&#8217; IP-10. Questo rappresenta un avanzamento significativo rispetto ai tradizionali test di rilascio dell\u2019interferone-gamma. Questo innovativo metodo diagnostico si basa sulla rilevazione del biomarcatore IP-10 (proteina indotta da interferone-gamma 10), che viene secreto in concentrazioni fino a 100 volte superiori rispetto all&#8217;INF-gamma, [&hellip;]","og_url":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/","og_site_name":"Clinical Diagnostics","article_published_time":"2024-12-04T15:26:14+00:00","article_modified_time":"2024-12-20T11:23:39+00:00","og_image":[{"width":930,"height":339,"url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg","type":"image\/jpeg"}],"author":"simonpatasic","twitter_misc":{"Written by":"simonpatasic","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#article","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/"},"author":{"name":"simonpatasic","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d"},"headline":"Nuovo strumento per la lotta contro la Tubercolosi (TB)","datePublished":"2024-12-04T15:26:14+00:00","dateModified":"2024-12-20T11:23:39+00:00","mainEntityOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/"},"wordCount":240,"image":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg","articleSection":["Diagnostica della tubercolosi"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/","url":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/","name":"Nuovo strumento per la lotta contro la Tubercolosi (TB) - Clinical Diagnostics","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage"},"image":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg","datePublished":"2024-12-04T15:26:14+00:00","dateModified":"2024-12-20T11:23:39+00:00","author":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d"},"breadcrumb":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#primaryimage","url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg","contentUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/12\/2024-11_website_news-bilder_tb_rs-rq-q3.jpg","width":930,"height":339},{"@type":"BreadcrumbList","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/r-biopharm-introduce-un-nuovo-strumento-per-la-lotta-contro-la-tubercolosi-tb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinical.r-biopharm.com\/it\/home\/"},{"@type":"ListItem","position":2,"name":"Nuovo strumento per la lotta contro la Tubercolosi (TB)"}]},{"@type":"WebSite","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website","url":"https:\/\/clinical.r-biopharm.com\/fr\/","name":"Clinical Diagnostics","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/cc75e096468dead4da2680d215eda71d","name":"simonpatasic","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ece836a5d732f88c095eac6e0cccdde834cf8509c9c57d650e20ad1a0c0637bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ece836a5d732f88c095eac6e0cccdde834cf8509c9c57d650e20ad1a0c0637bd?s=96&d=mm&r=g","caption":"simonpatasic"}}]}},"_links":{"self":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/180837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/users\/330"}],"replies":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/comments?post=180837"}],"version-history":[{"count":8,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/180837\/revisions"}],"predecessor-version":[{"id":180849,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/180837\/revisions\/180849"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/media\/180800"}],"wp:attachment":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/media?parent=180837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/categories?post=180837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/tags?post=180837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}